Glimepiride Metformin Hydrochloride Sustained Release Tablets

Glimepiride (1-4 mg) and Metformin Hydrochloride (500-1000 mg) Sustained Release (SR) is a combination medication for treating type 2 diabetes mellitus in adults. It manages high blood glucose by stimulating insulin release (glimepiride) and reducing hepatic glucose production while increasing insulin sensitivity (metformin). The sustained-release formula ensures a steady, long-acting effect.